- Home
- ADD vs TENX Comparison
ADD vs TENX Comparison
Compare ADD & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADD
- TENX
- Stock Information
- Founded
- ADD 2002
- TENX 1967
- Country
- ADD United States
- TENX United States
- Employees
- ADD N/A
- TENX N/A
- Industry
- ADD Engineering & Construction
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- ADD Consumer Discretionary
- TENX Health Care
- Exchange
- ADD Nasdaq
- TENX Nasdaq
- Market Cap
- ADD 25.4M
- TENX 21.6M
- IPO Year
- ADD N/A
- TENX N/A
- Fundamental
- Price
- ADD $1.03
- TENX $5.83
- Analyst Decision
- ADD
- TENX Strong Buy
- Analyst Count
- ADD 0
- TENX 3
- Target Price
- ADD N/A
- TENX $16.00
- AVG Volume (30 Days)
- ADD 451.7K
- TENX 41.0K
- Earning Date
- ADD 06-25-2025
- TENX 08-12-2025
- Dividend Yield
- ADD N/A
- TENX N/A
- EPS Growth
- ADD N/A
- TENX N/A
- EPS
- ADD N/A
- TENX N/A
- Revenue
- ADD $1,770,000.00
- TENX N/A
- Revenue This Year
- ADD N/A
- TENX N/A
- Revenue Next Year
- ADD N/A
- TENX N/A
- P/E Ratio
- ADD N/A
- TENX N/A
- Revenue Growth
- ADD 66.91
- TENX N/A
- 52 Week Low
- ADD $0.56
- TENX $2.80
- 52 Week High
- ADD $185.00
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- ADD 54.85
- TENX 50.54
- Support Level
- ADD $0.87
- TENX $5.68
- Resistance Level
- ADD $1.03
- TENX $5.98
- Average True Range (ATR)
- ADD 0.09
- TENX 0.39
- MACD
- ADD 0.01
- TENX 0.00
- Stochastic Oscillator
- ADD 74.10
- TENX 18.87
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.